About
Ticagrelor is an oral antiplatelet agent that reversibly binds to the P2Y12 receptor on platelets, preventing adenosine diphosphate (ADP)-induced platelet activation and aggregation. This mechanism reduces the risk of thrombotic events in patients with acute coronary syndromes (ACS) or a history of myocardial infarction (MI). Its rapid onset of action and reversible binding distinguish it from some other antiplatelet agents, making it a crucial component in dual antiplatelet therapy (DAPT) regimens. Clinical trials have demonstrated its efficacy in reducing cardiovascular death, MI, and stroke in specific patient populations, particularly when used in conjunction with aspirin. It is a vital medication for secondary prevention of cardiovascular events.
Uses
- Prevention of thrombotic events in acute coronary syndrome (ACS).
- Reduction of cardiovascular death, MI, and stroke in patients with a history of MI.
- Prevention of stent thrombosis after percutaneous coronary intervention (PCI).
- Used in conjunction with aspirin for dual antiplatelet therapy.
Directions For Use
Take orally as directed by your physician, usually twice daily. Do not crush or chew the tablet.
Benefits
- Significantly reduces risk of major adverse cardiovascular events.
- Faster onset of action compared to some other antiplatelets.
- Reversible platelet inhibition.
- Effective in patients with acute coronary syndromes.
- Reduces risk of stent thrombosis.
- Improved outcomes in post-myocardial infarction patients.
Side Effects
- Bleeding (e.g., bruising, nosebleeds)
- Dyspnea (shortness of breath)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Rash
- Bradycardia
- Hypotension
- Hyperuricemia
- Gout
- Syncope
Safety Measures
- Alcohol - Alcohol can increase the risk of bleeding when combined with ticagrelor; use with caution and in moderation.
- Pregnancy - Generally not recommended during pregnancy due to potential fetal harm and increased bleeding risk; consult a doctor.
- Breastfeeding - It is unknown if ticagrelor passes into breast milk; breastfeeding is generally not recommended.
- Liver - Use with caution in patients with moderate hepatic impairment; contraindicated in severe hepatic impairment.
- Kidney - No dose adjustment is typically needed for renal impairment, but monitor for bleeding risk.
- Lung - May cause dyspnea; use with caution in patients with pre-existing respiratory conditions like asthma or COPD.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!